Candel Therapeutics shares positive survival data for investigational immunotherapy in NSCLC

By Proactive Investors / March 27, 2025 / www.youtube.com / Article Link

Candel Therapeutics CEO Dr. Paul Peter Tak joined Steve Darling from Proactive to announce final survival data from a Phase 2a ...

Recent News

Gold stocks outperform equities surge

May 11, 2026 / www.canadianminingreport.com

Global tech once again leading the markets in 2026

May 11, 2026 / www.canadianminingreport.com

Strong Q1/26 results continue with Agnico, Kinross and Alamos reporting

May 04, 2026 / www.canadianminingreport.com

Gold stocks decline as equities reach all-time highs

May 04, 2026 / www.canadianminingreport.com

Gold stocks decline on metal pullback

April 27, 2026 / www.canadianminingreport.com

See all >